CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $583,286 | +2112.4% | 21,195 | +2627.8% | 0.00% | – |
Q2 2023 | $26,364 | -98.8% | 777 | -98.7% | 0.00% | -100.0% |
Q1 2023 | $2,190,282 | -58.8% | 60,875 | -48.9% | 0.00% | -50.0% |
Q4 2022 | $5,314,661 | +412.0% | 119,243 | +222.9% | 0.00% | – |
Q3 2022 | $1,038,000 | -66.3% | 36,928 | -67.7% | 0.00% | -100.0% |
Q2 2022 | $3,081,000 | -43.7% | 114,278 | -28.9% | 0.00% | -50.0% |
Q1 2022 | $5,476,000 | +8.5% | 160,779 | +23.1% | 0.00% | +100.0% |
Q4 2021 | $5,046,000 | +97.5% | 130,590 | +175.9% | 0.00% | 0.0% |
Q3 2021 | $2,555,000 | +276.3% | 47,326 | +133.0% | 0.00% | – |
Q2 2021 | $679,000 | -39.9% | 20,313 | -63.0% | 0.00% | – |
Q1 2021 | $1,130,000 | +2254.2% | 54,849 | +1888.7% | 0.00% | – |
Q4 2020 | $48,000 | +108.7% | 2,758 | +75.7% | 0.00% | – |
Q3 2020 | $23,000 | +228.6% | 1,570 | +166.1% | 0.00% | – |
Q2 2020 | $7,000 | +600.0% | 590 | -34.2% | 0.00% | – |
Q1 2020 | $1,000 | -66.7% | 897 | -40.8% | 0.00% | – |
Q4 2019 | $3,000 | -70.0% | 1,515 | -68.1% | 0.00% | – |
Q3 2019 | $10,000 | 0.0% | 4,747 | +35.6% | 0.00% | – |
Q2 2019 | $10,000 | +900.0% | 3,501 | +1641.8% | 0.00% | – |
Q1 2019 | $1,000 | – | 201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |